logo
Select company
Select metric
-7668.68%Free Cash Flow Margin
VS
Market
2
Sector
6
Industry
12
History
33
$ 2.41Close
$ 1.95 - $ 5.35 52-Week Range
Ticker Information

Ticker

CRDF

Company Name

CARDIFF ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARDIFF ONCOLOGY INC - Free Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRDF - FCF % Historical data
DateFree Cash FlowFree Cash Flow MarginRevenues
6/30/2025$ -41.87M-7668.68%$ 546K
3/31/2025$ -42.75M-7269.9%$ 588K
12/31/2024$ -37.77M-5530.45%$ 683K
9/30/2024$ -34.65M-5029.46%$ 689K
6/30/2024$ -32.47M-4882.56%$ 665K
3/31/2024$ -30.62M-5020%$ 610K
12/31/2023$ -31.47M-6448.57%$ 488K
9/30/2023$ -33.79M-7345%$ 460K
6/30/2023$ -33.45M-8118.69%$ 412K
3/31/2023$ -33.07M-8372.91%$ 395K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARDIFF ONCOLOGY INC's latest trailing twelve months (TTM) FCF % stands at -4309.17%.
  • Over the past 5 years, CARDIFF ONCOLOGY INC's average FCF % has been -6503.18%.
  • The median FCF % for CARDIFF ONCOLOGY INC during this period was -6461.75%
  • CARDIFF ONCOLOGY INC reached its highest FCF % over the past 5 years at -4309.17%.
  • The lowest FCF % recorded by CARDIFF ONCOLOGY INC in the same timeframe -9022.28%

CARDIFF ONCOLOGY INC's FCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF % Benchmarks
CompanyFCF %
MREO : MEREO BIOPHARMA GROUP PLC -6587.8%AVTX : AVALO THERAPEUTICS INC -10752.38%HUMA : HUMACYTE INC -12994.01%COYA : COYA THERAPEUTICS INC -3890.1%VTGN : VISTAGEN THERAPEUTICS INC -7784.52%ABEO : ABEONA THERAPEUTICS INC -17822.75%ABVC : ABVC BIOPHARMA INC -448.8%LYEL : LYELL IMMUNOPHARMA INC -324522.64%CURX : CURANEX PHARMACEUTICALS INC -MNPR : MONOPAR THERAPEUTICS -

Definition of Free Cash Flow Margin

[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
FCF / Revenues
(=) FCF %
FCF % for CARDIFF ONCOLOGY INC is calculated as follows: FCF [ $ -14.62M ] / Revenues [ $ 339.31K ]
(=) FCF % [ -4309.17% ]

CRDF - Free Cash Flow Margin, Last 5 years

-9022.28%

Minimum

Dec 31, 2022

-4309.17%

Maximum

Sep 30, 2020

-6503.18%

Average

-6461.75%

Median

FCF % Benchmark Analysis

The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.85% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
filtered constituents3.18K
min-58.23%
max68.19%
average7.85%
median7.37%
std19.48%